Brain imaging offers a way to examine how different regions of the brain participate in cognitive function”— Dr.

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026Initial data ...

Telix has resubmitted the NDA with the additional data requested by the FDA. The Company believes, based on the Type A meeting and ongoing consultation with the FDA, that the additional data and ...

MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the resubmission of a New Drug Application (NDA) to ...

In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

Telix Pharmaceuticals has resubmitted its FDA application for TLX101-Px, a new brain cancer imaging candidate. The post Telix Pharmaceuticals resubmits FDA application for brain cancer imaging agent ...

ASX healthcare stocks remain under pressure, but strong clinical and regulatory catalysts are still driving standout gains ...

You’ve probably heard someone say exercise is “good for your head.” And you’ve probably nodded, filed it under vaguely true ...

Telix Pharmaceuticals ( (AU:TLX)) has issued an announcement. Telix Pharmaceuticals has resubmitted a New Drug Application to the U.S. FDA for TLX101-Px (Pixclara), an F-18 FET PET imaging agent ...

Betsi Cadwaladr University Health Board’s CEO apologised 'for the unacceptable delays' ...

A 16-day-old baby with rare Hyperinsulinism saved by world’s first robotic pancreatic surgery, marking a groundbreaking ...

Alzheimer’s disease is devastating to families and many of those patients also suffer from heart problems. Pioneering MUSC research show the same toxic proteins cause both, with potential for therapy.